Properties of Materials Used in Single-Use Flexible Containers: Requirements and Analysis - - BioPharm International

ADVERTISEMENT

Properties of Materials Used in Single-Use Flexible Containers: Requirements and Analysis


BioPharm International


A standard matrix with a large number of solvents usually can be referenced for the initial evaluation of the compatibility of a film with a solution. If a container is to be used with a solution that is not on this list, two options are available, depending on the process risk analysis. The first option is to compare the new solution with a solution that has been tested already. If the solutions are similar, then the compatibility can be considered similar. The second option is to conduct a study with the specific solution and under the specific conditions of use.


Abbreviations and Definitions
Extractable and leachables. The purpose of extractables and leachables studies is to determine the possible impurities (extractables or leachables) that can come out of the films. A model solvent approach is commonly used to determine the amount and type of extractables under conditions that are more aggressive than normal operating parameters. A leachables study is normally carried out with a specific solution and conditions (time and storage) that are similar to operating parameters. The types of tests that are usually carried out will make it possible to identify and quantify volatile, semi-volatile, and nonvolatile products as well as heavy metals that can be leached from the film. Once again, a process risk analysis will determine the extent of these studies, mainly depending on the proximity of the process to the final drug delivery.

Protein adsorption. Protein adsorption can be approached in two general ways. The first approach is to conduct classical potency testing at various stages of product storage and then determine if any adsorption has taken place. The second approach can be used as a basis to estimate the potential loss of proteins upon contact with the film's surface. This second approach quantitatively evaluates the amount of "model" proteins that can adhere to a polymeric surface and compares that to the amount that can adhere to a glass surface.48

Product integrity

Regardless of the production step in which a single-use container is used, the physical and microbial integrity of the complete product must be guaranteed. Depending on the production stage, this guarantee can be achieved in various ways. A 100% leak test conducted before use can be considered the ultimate guarantee. In some cases, however, this type of testing can be destructive or weaken the product. The highest level of integrity guarantee is achieved by having a capable and validated manufacturing process. Common tests used to conduct process validation on single-use equipment include seal testing, burst testing, drop testing, air leak testing, ship testing, and microbial ingress testing. These tests are generally described in well known standards (e.g. ASTM, ISO).

Most importantly, it is the final product that is validated and not its individual components (films, connectors, tubing, etc.). The integrity of the product is determined by its weakest link; it is not necessary to have bag seals that are twice as strong as the connection of the tubing to a bag, because the connection will fail long before the seals are stressed.

Expiry dating

Product aging needs to be considered for most of the tests and qualifications mentioned above. Polymeric materials are known to age and their physical and compatibility properties may change with time. These changes can be increased by gamma irradiation and need to be measured either through natural ageing or under accelerated ageing conditions.49

Examples of Polymer Choices for Single-Use Applications

Example 1:

Input data: Need to store 200 L of product for two to four weeks at 2 to 8 C. Solution is at pH 5, needs mixing, and is sensitive to oxygen. Container needs to be aseptically filled.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here